Effect of a Major Depressive Disorder History and of Bupropion Treatment on Smoking-Induced Dopamine Release

被引：0
|
作者：
Brody, Arthur [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
662
引用
收藏
页码：187S / 187S
页数：1
相关论文
共 50 条
  • [41] Effect of bupropion for nicotine dependece in patients with major depressive disorder: an open clinical trial
    Kim, H.
    Lee, K. J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S375 - S376
  • [42] Dextromethorphan/bupropion in major depressive disorder: a profile of its use
    Blair, Hannah A.
    [J]. DRUGS & THERAPY PERSPECTIVES, 2023, 39 (08) : 270 - 278
  • [43] Bupropion - A review of its use in the management of major depressive disorder
    Dhillon, Sohita
    Yang, Lily P. H.
    Curran, Monique P.
    [J]. DRUGS, 2008, 68 (05) : 653 - 689
  • [44] Dextromethorphan/bupropion in major depressive disorder: a profile of its use
    Hannah A. Blair
    [J]. Drugs & Therapy Perspectives, 2023, 39 : 270 - 278
  • [45] Effect of bupropion extended release on negative emotion processing in major depressive disorder: A pilot functional magnetic resonance imaging study
    Robertson, Brigitte
    Wang, Lihong
    Diaz, Michele T.
    Aiello, Marilyn
    Gersing, Kenneth
    Beyer, John
    Mukundan, Srinivasan, Jr.
    McCarthy, Gregory
    Doraiswamy, P. Murali
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) : 261 - 267
  • [46] The under-recognized role of dopamine in the treatment of major depressive disorder
    Montgomery, Stuart A.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (02) : 63 - 69
  • [47] Relevance of Norepinephrine-Dopamine Interactions in the Treatment of Major Depressive Disorder
    El Mansari, Mostafa
    Guiard, Bruno P.
    Chernoloz, Olga
    Ghanbari, Ramez
    Katz, Noam
    Blier, Pierre
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (03) : e1 - e17
  • [48] Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline
    Rush, AJ
    Trivedi, MH
    Carmody, TJ
    Donahue, RMJ
    Houser, TL
    Bolden-Watson, C
    Batey, SR
    Ascher, JA
    Metz, A
    [J]. NEUROPSYCHOPHARMACOLOGY, 2001, 25 (01) : 131 - 138
  • [49] Response in Relation to Baseline Anxiety Levels in Major Depressive Disorder Treated with Bupropion Sustained Release or Sertraline
    A John Rush
    Madhukar H Trivedi
    Thomas J Carmody
    Rafe M J Donahue
    Trisha L Houser
    Carolyn Bolden-Watson
    Sharyn R Batey
    John A Ascher
    Alan Metz
    [J]. Neuropsychopharmacology, 2001, 25 : 131 - 138
  • [50] Development of major depressive disorder during smoking-cessation treatment
    Borrelli, B
    Niaura, R
    Keuthen, NJ
    Goldstein, MG
    DePue, JD
    Murphy, C
    Abrams, DB
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (11) : 534 - 538
12345